Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Allergy & Cold Medication Recalls

Recalls of antihistamines, decongestants and nasal sprays.

314 recalls in this category, newest first.

Class II · Moderate risk

Narcan (naloxone HCl)

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. NDC 69547-353-02 D-0473-2021
Class III · Low risk

Discount Drug Mart

Labeling: Incorrect or Missing Lot and/or Expiration date.

Terminated Labeling / mix-up AAA Pharmaceutical, Inc. NDC 53943-192-04 D-0868-2020
Class II · Moderate risk

Allergy Relief

Failed Impurities/Degradation Specifications

Terminated Impurity / degradation Aurolife Pharma, LLC NDC 49035-995-62 D-1869-2019
Class II · Moderate risk

Allergy Relief

Failed Impurities/Degradation Specifications

Terminated Impurity / degradation Aurolife Pharma, LLC NDC 46122-387-23 D-1866-2019
Class II · Moderate risk

Allergy Relief

Failed Impurities/Degradation Specifications

Terminated Impurity / degradation Aurolife Pharma, LLC NDC 60000-409-53 D-1865-2019
Class II · Moderate risk

Diphenhydramine HCL Liquid

Microbial Contamination of Non-sterile Products: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Terminated Microbial contamination H J Harkins Company Inc dba Pharma Pac NDC 52959-0123-03 D-1430-2019
Class II · Moderate risk

Cetirizine Oral Solution 1 mg/mL

cGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL, 4oz, of the voluntary recall that they have initiated due to potential contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Terminated Microbial contamination P & L Developments, LLC NDC 11673-178-04 D-1409-2019